DXCMNASDAQLive delayed
$73.37
+1.83+2.56%
SourceCNBCAs ofJul 27, 2026, 8:00 PM
Delayed market data from CNBC. Not investment advice.
DexCom is a healthcare name tracked on StockWatch with delayed quotes, charts, and related news. Home market: United States.
Key statistics
Delayed fundamentals for DXCM · Finnhub.
- Market cap
- $28.50B
- P/E (TTM)
- 34.08
- EPS (TTM)
- $2.3141
- Div. yield
- —
- 52-week range
- $54.11 – $89.98
- Volume
- —
- Avg volume
- 4.06M
Price history
OHLC candles for DXCM · 3mo · 1day · Twelve Data · EMA / RSI
+19.81%periodDirect mentions, stories that impact this name, and related market themes — with Impact Analysis on each headline.
DirectHigh impactGlobalLikely supportiveGoogle News
DXCM Q2 Results Likely to Reflect Strong G7 & Reimbursement ExpansionDXCM Q2 Results Likely to Reflect Strong G7 & Reimbursement Expansion TradingViewSolid growth data can support earnings expectations.
Watch: DXCM · .SPX · .DJI · CAT
DirectHigh impactGoogle News
DexCom (DXCM) Wins Health Canada Approval, Is The Stock Trading At A Discount?DirectHigh impactGoogle News
Does DexCom’s (DXCM) Longer-Wear G7 Approval Hint At A Durable Edge In Connected Diabetes Care?DirectHigh impactGoogle News
Insider Sale: EVP of $DXCM Sells 1,700 SharesDirectHigh impactGoogle News
DexCom (DXCM) Earnings Expected to Grow: Should You Buy?DirectHigh impactGoogle News
Dexcom to Test AI Glucose Program for Prediabetes ScreeningDirectHigh impactGoogle News
At US$74.75, Is It Time To Put DexCom, Inc. (NASDAQ:DXCM) On Your Watch List?DirectHigh impactGoogle News
Insider Sale: Executive Chair of $DXCM Sells 26,756 Shares